Oracle Stock Plummets Amid Wall Street Buy Consensus
Oracle’s stock has fallen 50% from its September high, despite strong buy ratings from Wall Street analysts. As of May 2, 2026, 41 out of 51 analysts rate Oracle a buy, suggesting a significant upside potential. This optimism contrasts sharply with the stock’s recent performance, having dropped nearly 50% since its peak in September, and 14% in the six trading sessions leading up to Thursday.
The $300B OpenAI Deal: A Point of Contention
The primary driver behind Oracle’s stock decline is its $300 billion partnership with OpenAI, announced in January 2025. This deal, which involves providing cloud computing infrastructure for OpenAI’s Stargate AI joint venture, has raised concerns among investors. These fears center on potential circular financing risks and OpenAI’s ability to honor its significant infrastructure commitments.
Despite Oracle’s impressive 95% jump in net income and substantial increase in performance obligations, investors remain skeptical. The primary concern revolves around OpenAI, which has shown missed revenue targets and cash burn concerns, raising questions about its capacity to pay for the substantial cloud infrastructure it has contracted.
Analyst vs. Investor Perspective
Wall Street analysts argue that demand for AI infrastructure is fungible and Oracle is undervalued. They maintain buy ratings, citing Oracle’s strong fundamentals and growth potential. However, investors are selling, driven by concerns about OpenAI’s financial stability and the potential implications for Oracle’s investment.
The divergence between analyst optimism and investor skepticism highlights the complexities of evaluating Oracle’s current situation. While analysts focus on the broader market dynamics and Oracle’s technological advantages, investors are zeroing in on the specific risks associated with its OpenAI partnership.